Quote:

---

I gotta wonder if Brazil was Nader’s pet project

---

Knowing why the initial trial failed and how to correct it in future trials it certainly is a worthwhile pet project. Not only because approval means revenues but it's a big FU to the FDA and their chicanery can be exposed.